EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Progyny's Enterprise Value is $2,758 Mil.
Progyny's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $62 Mil. Therefore, Progyny's EV-to-EBIT for today is 44.36.
The historical rank and industry rank for Progyny's EV-to-EBIT or its related term are showing as below:
PGNY'
s EV-to-EBIT Range Over the Past 10 Years
Min: 44.2 Med: 178.3 Max: 591.58
Current: 44.36
During the past 7 years, the highest EV-to-EBIT of Progyny was 591.58. The lowest was 44.20. And the median was 178.30.
PGNY's EV-to-EBIT is ranked worse than 86.92% of 428
companies
in the Healthcare Providers & Services industry
Industry Median: 18.59
vs PGNY: 44.36
The historical data trend for Progyny's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Progyny's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progyny's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Progyny's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Progyny's EV-to-EBIT falls into.
Progyny's current Enterprise Value is $2,758 Mil.
Progyny's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progyny (NAS:PGNY) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Progyny's Enterprise Value for the quarter that ended in Dec. 2023 was $3,231 Mil.
Progyny's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progyny EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Progyny's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PGNY has been successfully added to your 